GAVILAX 17 g/17g (Polyethylene Glycol 3350 POWDER, FOR SOLUTION) 17 g/17g

Gavilax 17 g/17g is a powder for solution containing Polyethylene Glycol 3350, used for bowel cleansing before medical procedures. This oral solution helps prepare the intestines for colonoscopy or surgery.

Strength

17 g/17g

Pack Size

8.5 g in 1 BAG (17856-0312-2)

Manufacturer / TM Owner

ATLANTIC BIOLOGICALS CORP.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gavilax 17 g/17g is primarily used for bowel cleansing to clear the intestines before colonoscopy, surgery, or other medical procedures. Polyethylene Glycol 3350 works by drawing water into the colon, softening stool, and promoting bowel movements. This helps ensure a clear view of the colon during diagnostic procedures.

Side Effects

When taken as directed, Gavilax 17 g/17g typically causes frequent bowel movements and loose stools. Some users may experience bloating, nausea, or abdominal discomfort. These effects are generally temporary and subside once the bowel cleansing process is complete.

Precautions & Warnings

Gavilax 17 g/17g should be used with caution in individuals with a history of bowel obstruction, severe ulcerative colitis, or toxic megacolon. It is important to stay hydrated during use and follow the instructions provided by a healthcare professional. Do not use if you are allergic to Polyethylene Glycol 3350.

Avoid Interactions

Gavilax 17 g/17g may interact with certain medications, including antacids, laxatives, and some antibiotics. It is advisable to consult a healthcare professional before using this product if you are taking other medications. Alcohol and certain foods may also affect the effectiveness of the solution.

Frequently Asked Questions

Gavilax 17 g/17g is used for bowel cleansing before medical procedures like colonoscopy or surgery.

Polyethylene Glycol 3350 draws water into the colon, softening stool and promoting bowel movements.

Common side effects include frequent bowel movements, bloating, nausea, and abdominal discomfort.

Consult a healthcare professional before using Gavilax 17 g/17g with other medications to avoid potential interactions.

Gavilax 17 g/17g should be used with caution in individuals with certain medical conditions, such as bowel obstruction or severe ulcerative colitis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.